Farmaceutica R (RMAH) — Net Asset Momentum
Farmaceutica R (RMAH) recorded a net asset momentum of 7.7% as of September 2025, with net assets of RON79.61 Million RON. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See RMAH book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Farmaceutica R Net Asset Momentum (2020–2025)
This chart tracks Farmaceutica R's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is +7.7%, with net assets of RON79.61 Million RON as of September 2025. Check how tangible is Farmaceutica R's equity to evaluate the tangible quality of the company's equity base.
Annual Net Asset History for Farmaceutica R (2020–2025)
The table below shows the complete annual net asset history for Farmaceutica R from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of Farmaceutica R.
| Year | Net Assets (RON) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | RON79.61 Million | RON383.19 Million | RON303.58 Million | ▲ +7.7% |
| 2024 | RON73.94 Million | RON375.04 Million | RON301.09 Million | ▲ +4.4% |
| 2023 | RON70.86 Million | RON315.76 Million | RON244.90 Million | ▲ +3.5% |
| 2022 | RON68.43 Million | RON286.20 Million | RON217.77 Million | ▲ +0.3% |
| 2021 | RON68.22 Million | RON251.07 Million | RON182.85 Million | ▼ -14.5% |
| 2020 | RON79.83 Million | RON244.46 Million | RON164.63 Million | — |